Literature DB >> 22012471

ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex.

Katharina Domschke1, Agnieszka Gajewska, Bernward Winter, Martin J Herrmann, Bodo Warrings, Andreas Mühlberger, Katherina Wosnitza, Evelyn Glotzbach, Annette Conzelmann, Andrea Dlugos, Manfred Fobker, Christian Jacob, Volker Arolt, Andreas Reif, Paul Pauli, Peter Zwanzger, Jürgen Deckert.   

Abstract

There is converging evidence for genetic, biochemical, and neuropsychological factors to increase the risk for anxiety and anxiety disorders. The pathogenesis of anxiety disorders is assumed to be influenced by a complex interaction of these individual risk factors on several levels, affecting intermediate phenotypes of anxiety such as the startle reflex. Thus, in the present double-blind, placebo-controlled study we attempted to paradigmatically investigate a multi-level pathogenetic model of anxiety by testing the effect of 300 mg caffeine citrate as an antagonist at the adenosine A2A receptor vs placebo on the emotion-potentiated (unpleasant, neutral, and pleasant International Affective Picture System pictures) startle reflex in 110 healthy individuals (male=56, female=54) stratified for the adenosine A2A receptor (ADORA2A) 1976T>C polymorphism (rs5751876). In addition to the expected main effect of picture category (highest startle amplitude for unpleasant, lowest for pleasant pictures) groups across all ADORA2A 1976T>C genotype and intervention (caffeine vs placebo) groups, an interaction effect of genotype, intervention, and picture category was discerned: In ADORA2A 1976TT risk genotype carriers, highest startle magnitudes were observed after caffeine administration in response to unpleasant pictures, with this effect arising particularly from the female subgroup. Our data point to a complex, multi-level, and potentially gender-specific pathogenetic model of anxiety, with genetic and biochemical factors interactively increasing the risk of maladaptive emotional processing and thereby possibly also anxiety disorders. The present findings may eventually aid in improving primary and secondary prevention by sharpening the risk profiles of anxiety-prone individuals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22012471      PMCID: PMC3260968          DOI: 10.1038/npp.2011.253

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  91 in total

1.  Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder.

Authors:  J Deckert; M Catalano; Y V Syagailo; M Bosi; O Okladnova; D Di Bella; M M Nöthen; P Maffei; P Franke; J Fritze; W Maier; P Propping; H Beckmann; L Bellodi; K P Lesch
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

2.  Threat is in the eye of the beholder: social anxiety and the interpretation of ambiguous facial expressions.

Authors:  K Lira Yoon; Richard E Zinbarg
Journal:  Behav Res Ther       Date:  2006-06-23

3.  Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD.

Authors:  R W Butler; D L Braff; J L Rausch; M A Jenkins; J Sprock; M A Geyer
Journal:  Am J Psychiatry       Date:  1990-10       Impact factor: 18.112

Review 4.  Affective information processing and the assessment of anxiety.

Authors:  P J Lang; B N Cuthbert
Journal:  J Behav Assess       Date:  1984-12

5.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

6.  Caffeine intake, tolerance, and withdrawal in women: a population-based twin study.

Authors:  K S Kendler; C A Prescott
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

7.  The effects of different doses of caffeine on habituation of the human acoustic startle reflex.

Authors:  E J Schicatano; T D Blumenthal
Journal:  Pharmacol Biochem Behav       Date:  1995-09       Impact factor: 3.533

Review 8.  Imaging genetics of anxiety disorders.

Authors:  Katharina Domschke; Udo Dannlowski
Journal:  Neuroimage       Date:  2009-11-26       Impact factor: 6.556

Review 9.  Models and mechanisms of anxiety: evidence from startle studies.

Authors:  Christian Grillon
Journal:  Psychopharmacology (Berl)       Date:  2007-12-06       Impact factor: 4.530

10.  Anxiety and mood disorders in children and adolescents: A practice update.

Authors:  S J Bradley
Journal:  Paediatr Child Health       Date:  2001-09       Impact factor: 2.253

View more
  18 in total

1.  PharmGKB summary: caffeine pathway.

Authors:  Caroline F Thorn; Eleni Aklillu; Ellen M McDonagh; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2012-05       Impact factor: 2.089

Review 2.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

3.  Modification of caffeine effects on the affect-modulated startle by neuropeptide S receptor gene variation.

Authors:  Katharina Domschke; Benedikt Klauke; Bernward Winter; Agnes Gajewska; Martin J Herrmann; Bodo Warrings; Andreas Mühlberger; Katherina Wosnitza; Andrea Dlugos; Swantje Naunin; Kathrin Nienhaus; Manfred Fobker; Christian Jacob; Volker Arolt; Paul Pauli; Andreas Reif; Peter Zwanzger; Jürgen Deckert
Journal:  Psychopharmacology (Berl)       Date:  2012-03-08       Impact factor: 4.530

4.  Is prepulse modification altered by continuous theta burst stimulation? DAT1 genotype and motor threshold interact on prepulse modification following brain stimulation.

Authors:  S Notzon; N Vennewald; A Gajewska; A L Klahn; J Diemer; B Winter; I Fohrbeck; V Arolt; P Pauli; K Domschke; P Zwanzger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-24       Impact factor: 5.270

5.  Emotional processing and rTMS: does inhibitory theta burst stimulation affect the human startle reflex?

Authors:  Nadja Vennewald; Bernward Winter; Karina Limburg; Julia Diemer; Swantje Notzon; Inga Fohrbeck; Volker Arolt; Katharina Domschke; Paul Pauli; Peter Zwanzger
Journal:  J Neural Transm (Vienna)       Date:  2016-05-13       Impact factor: 3.575

6.  GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder.

Authors:  J Deckert; H Weber; C Villmann; T B Lonsdorf; J Richter; M Andreatta; A Arias-Vasquez; L Hommers; L Kent; C Schartner; S Cichon; C Wolf; N Schaefer; C R von Collenberg; B Wachter; R Blum; D Schümann; R Scharfenort; J Schumacher; A J Forstner; C Baumann; M A Schiele; S Notzon; P Zwanzger; J G E Janzing; T Galesloot; L A Kiemeney; A Gajewska; E Glotzbach-Schoon; A Mühlberger; G Alpers; T Fydrich; L Fehm; A L Gerlach; T Kircher; T Lang; A Ströhle; V Arolt; H-U Wittchen; R Kalisch; C Büchel; A Hamm; M M Nöthen; M Romanos; K Domschke; P Pauli; A Reif
Journal:  Mol Psychiatry       Date:  2017-02-07       Impact factor: 15.992

7.  Multilevel impact of the dopamine system on the emotion-potentiated startle reflex.

Authors:  Katharina Domschke; Bernward Winter; Agnieszka Gajewska; Stefan Unterecker; Bodo Warrings; Andrea Dlugos; Swantje Notzon; Kathrin Nienhaus; Falko Markulin; Astrid Gieselmann; Christian Jacob; Martin J Herrmann; Volker Arolt; Andreas Mühlberger; Andreas Reif; Paul Pauli; Jürgen Deckert; Peter Zwanzger
Journal:  Psychopharmacology (Berl)       Date:  2014-12-17       Impact factor: 4.530

Review 8.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

9.  The RS685012 Polymorphism of ACCN2, the Human Ortholog of Murine Acid-Sensing Ion Channel (ASIC1) Gene, is Highly Represented in Patients with Panic Disorder.

Authors:  Agnese Gugliandolo; Chiara Gangemi; Daniela Caccamo; Monica Currò; Gianluca Pandolfo; Diego Quattrone; Manuela Crucitti; Rocco Antonio Zoccali; Antonio Bruno; Maria Rosaria Anna Muscatello
Journal:  Neuromolecular Med       Date:  2015-11-20       Impact factor: 3.843

Review 10.  Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.

Authors:  Alexandre A Guerin; Eric J Nestler; Michael Berk; Andrew J Lawrence; Susan L Rossell; Jee Hyun Kim
Journal:  Neurosci Biobehav Rev       Date:  2020-11-17       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.